COVID-19 Study Reveals Subtle Differences in Immune Responses Between Infection and Vaccination

Strategic Insights -

Research published in the journal Vaccines has shed light on the immune response elicited by COVID-19 infection and vaccination. A team of researchers from Cellular Technology Ltd. (CTL) in Ohio, USA, conducted a comprehensive analysis of SARS-CoV-2 Spike (S-antigen)-reactive memory B cells (B[mem]) in previously immunologically naive subjects who underwent their first infection with the original Wuhan-Hu-1 (WH1)-like strain or received their initial COVID-19 mRNA prime-boost regimen encoding the same WH1-S-antigen.

Key Takeaways:

  • The primary encounter of SARS-CoV-2 S-antigen in lung mucosal tissues during infection versus intramuscular COVID-19 mRNA injection elicited different B[mem] responses, with ~30% of induced B[mem] targeting the receptor binding domain (RBD) of the WH1-S-antigen.
  • IgA+ B[mem] were preferentially induced after infection, while IgG4+ B[mem] were detected only after vaccination.
  • The B[mem] repertoires generated post-infection versus post-vaccination were found to be quite similar, with some subtle differences, including the induction of IgG1-expressing B[mem] in similar frequencies.
  • The extent of cross-reactivity with the future Omicron (BA.1) RBD was found to be similar for both cohorts.
  • The study concluded that B[mem] elicited in naive human subjects following SARS-CoV-2 infection or after WH1-S encoding mRNA vaccination were only subtly different, although the relevance of these differences as it relates to immune protection warrants further investigation.

Statistics:

  • ~30% of induced B[mem] targeted the receptor binding domain (RBD) of the WH1-S-antigen.
  • The extent of cross-reactivity with the future Omicron (BA.1) RBD was similar for both cohorts.
  • IgA+ B[mem] were preferentially induced after infection (~80%), while IgG4+ B[mem] were detected only after vaccination (~20%).
  • The study included 30 previously immunologically naive subjects who underwent their first infection with the original Wuhan-Hu-1 (WH1)-like strain or received their initial COVID-19 mRNA prime-boost regimen encoding the same WH1-S-antigen.

Sources:

  • SARS-CoV-2 Infection or COVID-19 mRNA Vaccination Elicits Partially Different Spike-Reactive Memory B Cell Responses in Naive Individuals. Vaccines, 2025,13(9):944. (Vaccines - http://www.mdpi.com/journal/vaccines)
  • Research and Development Researchers Have Provided New Data on COVID-19 (SARS-CoV-2 Infection or COVID-19 mRNA Vaccination Elicits Partially Different Spike-Reactive Memory B Cell Responses in Naive Individuals). Vaccine Weekly. October 15, 2025; p 361.